Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-06-02
2009-12-29
Blanchard, David J. (Department: 1643)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
07638485
ABSTRACT:
The use and screening of modulators of apoptosis is disclosed. The modulators may be, for example, modulator of NF-κB activity. The modulators may be used, for example, in the treatment of NF-κB-mediated diseases, conditions, and injuries.
REFERENCES:
patent: 5399494 (1995-03-01), Kaper et al.
patent: 6130082 (2000-10-01), Majarian et al.
Bachmann, M.F., Wolint, P., Schwarz, K., and Oxenius, A. Recall proliferation potential of memory CD8+ T cells and antiviral protection. 2005 Journal of Immunology, vol. 175, pp. 4677-4685.
Das, U.N. A radical approach to cancer. 2002 Medical Science Monitor, vol. 8 No. 4, pp. RA79-RA92.
Efferson,.C.L., Kawano, K., Tsuda, N., Palese, P., Garcia-Sastre, A., and Ioannides, C.G. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2
eu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. 2005 Anticancer Research vol. 25, pp. 715-724.
Wheeler, C.M. Preventative vaccines for cervical cancer. 1997, Salud Publica de Mexico, vol. 39 No. 4.
Androstenediol and Androstenedione. Wikipedia. http://en.wikipedia.org/wiki.
Definition of prophylaxis, Stedman's Medical Dictionary, 27thedition online, 2000.
Definition of prophylaxis, Merriam-Webster Medical Dictionary, online edition, 2005.
Cholera, Wikipedia, 2008.
Carnes et al., Radiation Research 160(2):159-167 (2003) (abstract only).
Burdelya et al., “An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models,” Science Apr. 11, 2008, (320) pp. 226-230.
Hall, “Physics and Chemistry of Radiation Absorption,” Radiobiology for the Radiobiologist, pp. 5-15, 5th ed., Lippincott Williams and Wilkins, Phila., PA, 2000.
Andreassen CN, et al., Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy, Semin Radiat Oncol., 2003;13(1):62-72.
Seed T, et al., New strategies for the prevention of radiation injury: possible implications for countering radiation hazards of long-term space travel, J Radiat Res, 2002;43 Suppl:S239-44.
Waddick KG, et al., In vitro and in vivo antileukemic activity of B43-pokeweed antiviral protein against radiation-resistant human B-cell precursor leukemia cells, Blood., 1995;86(11):4228-33.
Satyamitra M, et al., In vivo postirradiation protection by a vitamin E analog, alpha-TMG, Radiat Res. 2003;160 (6):655-61.
Eaves-Pyles TD, et al.,Salmonellaflagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein, J Immunol. Dec. 15, 2001;167(12):7009-16.
Sredni B, et al., The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent. Int J Immunopharrnacol, 1992;14(4):613-9.
Symon Z, et al., Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model, Int J Radiat Oncol Biol Phys., 2001;50(2):473-8.
Mutlu-Turkoglu U, et al., The effect of selenium and/or vitamin E treatments on radiation-induced intestinal injury in rats, Life Sci., 2000;66(20):1905-13.
Patchen ML, Amifostine plus granulocyte colony-stimulating factor therapy enhances recovery from supralethal radiation exposures: preclinical experience in animals models, Eur J Cancer., 1995;31A Suppl 1:S17-21.
Streeter PR, et al., Activation of the G-CSF and Flt-3 receptors protects hematopoietic stem cells from lethal irradiation, Exp Hematol., 2003;31(11):1119-25.
Wong GH, Protective roles of cytokines against radiation: induction of mitochondrial MnSOD, Biochim Biophys Acta., 1995:1271(1):205-9.
Whitnall MH, et al., In vivo radioprotection by 5-androstenediol: stimulation of the innate immune system, Radiat Res., 2001;156(3):283-93.
Blanchard David J.
Cleveland Biolabs, Inc.
Cleveland Clinic Foundation
Gussow Anne M.
Polsinelli Shughart PC
LandOfFree
Modulating apoptosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulating apoptosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulating apoptosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4070709